Behavior of insulin sensitivity and its relation to leptin and tumor necrosis factor-alpha in obese women undergoing liposuction: 6-Month follow-up

Obesity Surgery

Volumn 17, Issue 9, 2007, Pages 1242-1247

  Robles Cervantes, José Antonio ^a,b,d   Martínez Abundis, Esperanza ^a   González Ortiz, Manuel ^a   Cárdenas Camarena, Lázaro ^b   Hernández Salazar, Eduardo ^a   Olvera Ozuna, Rafael ^c  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b Health Ministry   (Mexico)

^c Radio Imagen de Occidente   (Mexico)

^d NONE   (Mexico)

Author keywords

Insulin resistance; Leptin; Liposuction; Obesity; Subcutaneous fat; Tumor necrosis factor alpha

Indexed keywords

CREATININE; GLUCOSE; GLUCOSE OXIDASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LEPTIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; UREA; URIC ACID; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN;

ADULT; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; COLORIMETRY; CORRELATION COEFFICIENT; CREATININE BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; FRIEDMAN TEST; GLUCOSE BLOOD LEVEL; GLUCOSE OXIDASE TECHNIQUE; HUMAN; INSULIN SENSITIVITY; INSULIN TOLERANCE TEST; INTRAABDOMINAL FAT; LIPOSUCTION; METABOLIC SYNDROME X; OBESITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RANK SUM TEST; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; SUBCUTANEOUS FAT; TECHNIQUE; TRIACYLGLYCEROL BLOOD LEVEL; UREA BLOOD LEVEL; URIC ACID BLOOD LEVEL; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; LIPECTOMY; METABOLISM; RANDOMIZED CONTROLLED TRIAL; TIME;

ADULT; FEMALE; FOLLOW-UP STUDIES; HUMANS; INSULIN; LEPTIN; LIPECTOMY; OBESITY; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 38549111128     PISSN: 09608923     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11695-007-9213-0     Document Type: Article

References (25)

1. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-607.
2. Bonora E, Targher G, Formentini G et al. The metabolic syndrome is an independent predictor of cardiovascular disease in Type 2 diabetic subjects. Prospective data from the Verona Diabetes Complications Study. Diabet Med 2004; 21: 52-8.
3. Kahn BB, Flier JS. Obesity and insulin resistance. J Clin Invest 2000; 106: 473-81.
4. Bonora E, DelPrato S, Bonadonna R et al. Total body fat content and fat topography are associated differently with in vivo glucose metabolism in nonobese and obese nondiabetic women. Diabetes 1992; 41: 1151-9.
5. Havel PJ. Update on adipocyte hormones: regulation of energy balance and carbohydrates/lipid metabolism. Diabetes 2004; 53 (Suppl 1): S143-S151.
6. van Dijk G, de Vries K, Benthem L et al. Neuroendocrinology of insulin resistance: metabolic and endocrine aspects of adiposity. Eur J Pharmacol 2003; 480: 31-42.
7. Misra A, Vikram NK. Clinical and pathophysiological consequences of abdominal adiposity and abdominal adipose tissue depots. Nutrition 2003; 19: 457-66.
8. Wajchenberg BL, Gianella-Neto D, da Silva ME et al. Depot-specific hormonal characteristics of subcutaneous and visceral adipose tissue and their relation to the metabolic syndrome. Horm Metab Res 2002; 34: 616-21.
9. Goodpaster BH, Thaete FL, Simoneau JA et al. Subcutaneous abdominal fat and thigh muscle composition predict insulin sensitivity independently of visceral fat. Diabetes 1997; 46: 1579-85.
10. Cazes L, Deitel M, Levine RH. Effect of abdominal lipectomy on lipid profile, glucose handling and blood pressure in patients with truncal obesity. Obes Surg 1996; 6: 159-66.
11. González-Ortiz M, Robles-Cervantes JA, Cárdenas- Camarena L et al. The effects of surgically removing subcutaneous fat on the metabolic profile and insulin sensitivity in obese women alter large-volume liposuction treatment. Horm Metab Res 2002; 34: 446-9.
12. Bonora E, Moghetti P, Zancanaro C et al. Estimates of in vivo insulin action in man: Comparison of insulin tolerance test with euglycemic and hyperglycemic glucose clamp studies. J Clin Endocrinol Metab 1989; 68: 374-8.
13. Talisman R, Belinson N, Modan-Moses D et al. The effect of reduction of the peripheral fat content by liposuction-assisted lipectomy (SAL) on serum leptin levels in the postoperative period: A prospective study. Aesth Plast Surg 2001; 25: 262-5.
14. Cnop M, Landchild MJ, Vidal J et al. The concurrent accumulation of intra-abdominal and subcutaneous fat explains the association between insulin resistance and plasma leptin concentrations. Diabetes 2002; 51: 1005-15.
15. Johannsson G, Karlsson C, Lonn L et al. Serum leptin concentration and insulin sensitivity in men with abdominal obesity. Obes Res 1998; 6: 416-21.
16. De Courten M, Zimmet P, Hodge A et al. Hyperleptinaemia: the missing link in the metabolic syndrome? Diabet Med 1997; 14: 200-8.
17. Silha JV, Krsek M, Skrha J et al. Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance. Eur J Endocrinol 2003; 149: 331-5.
18. Bullo M, García-Lorda P, Megias I et al Systemic inflammation, adipose tissue tumor necrosis factor, and leptin expression. Obes Res 2003; 11: 525-31.
19. Ziccardi P, Nappo F, Giugliano G et al. Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year. Circulation 2002; 105: 804-9.
20. Bullo M, García-Lorda P, Peinado-Onsurbe J et al TNFalpha expression of subcutaneous adipose tissue in obese and morbidly obese females: relationship to adipocyte LPL activity and leptin synthesis. Int J Obes 2002; 26: 652-8.
21. Bruun JM, Pedersen SB, Kristensen K et al. Effects of pro-inflammatory cytokines and chemokines on leptin production in human adipose tissue in vitro. Mol Cell Endocrinol 2002; 190: 91-9.
22. Iwai H, Ohno Y, Aoki N. The effect of leptin, tumor necrosis factor-alpha (TNF-alpha), and nitric oxide (NO) production on insulin resistance in Otsuka Long-Evans Fatty Rats. Endocr J 2003; 50: 673-80.
23. Molina A, Vendrell J, Gutierrez C et al. Insulin resistance, leptin and TNF-alpha system in morbidly obese women after gastric bypass. Obes Surg 2003; 13: 615-21.
24. Jensen MD. Is visceral fat involved in the pathogenesis of the metabolic syndrome? Obesity 2006; 14 (Suppl 1): 20S-24S.
25. Koutsari C, Jensen MD. Free fatty acid metabolism in human obesity. J Lipid Res 2006; 47: 1643-50.